Showing results (611-620 of 15,517) with videos related to
Sort By:
Pageof 1,552
International Immunopharmacology|February 13, 2026
CSF hCG in the crossroads of neurotoxicity and disease: Lessons from germ cell tumorAtoosa Etezadi, Pooyan Alizadeh, Nadia Talati Reveshti, et al.International Immunopharmacology|January 30, 2026
Umbilical cord mesenchymal stem cell-derived exosomes delivered via a thermosensitive hydrogel ameliorate atopic dermatitis by mitigating keratinocyte mitochondrial damage through activating the Wnt/β-catenin pathwayXueping Zhao, Yue Zhang, Yue Dong, et al.International Immunopharmacology|February 17, 2026
Association study between IL-33 gene DNA methylation and Pediatric asthmaYali Zhang, Lei Yan, Zhumei Li, et al.International Immunopharmacology|February 5, 2026
Exosomal MicroRNAs: From cellular communication to disease biomarkersReyhaneh Arefimehr, Ajaz AhmadInternational Immunopharmacology|February 17, 2026
Precision-based solutions for endometriosis: Integrating immunomics and drug repositioning strategiesHongyuan Li, Muyao Yang, Han Zhu, et al.International Immunopharmacology|February 17, 2026
VEGFR-1 blockade with the monoclonal antibody D16F7 counteracts VEGF-A-induced tolerogenic and immune regulatory phenotypes without impairing T-cell activationOrnella Franzese, Belinda Palermo, Pedro Miguel Lacal, et al.International Immunopharmacology|January 29, 2026
A novel mouse model of arthritis with enthesitis and heterotopic ossificationShanshan Kang, Shuqiong Zhang, Xingyi Wang, et al.International Immunopharmacology|February 1, 2026
CircUBXN7 as a prognostic risk biomarker for ARDS modulates LPS-stimulated lung epithelial cell injury and the inflammatory response by competitively binding miR-622Fan Xu, Yifan Chen, Yao Sun, et al.International Immunopharmacology|January 25, 2026
β-Sitosterol attenuates gentamicin-induced nephrotoxicity via ADAM-17/ACE2/Ang 1-7/MasR Axis modulation in ratsMohamed Gamal El-Din Ewees, Lobna A Abdelzaher, Ehab A M El-Shoura, et al.International Immunopharmacology|January 28, 2026
ResiDUBs: A deubiquitinating enzyme-based prognostic model identifies UBXN1 driving sorafenib resistance in liver cancerManqi Li, Yuxin Xie, Jinrui Wei, et al.Pageof 1,552